Veterinary Chemistry Analyzers Market Size, Share and Global Trend By Analyzer (Bench-Top Analyzers, Portable Analyzers), By Product (Instruments, Consumables), By Application (Blood chemistry analysis, Blood gas & electrolyte analysis, Urine analysis, Others), By End User (Veterinary hospitals & Clinics, Veterinary diagnostic centers), and Regional Forecast, 2024-2032

Veterinary chemistry analyzers are veterinary medical products used for the conductance of assays & biochemical testing in veterinary crucial for the diagnosis, monitoring, prevention, and treatment of diseases in animals. Veterinary chemistry analyzers are potent and critical tools for prevention of animal diseases and promotion of animal health and welfare, safe food production and public health. Veterinary chemistry analyzers have major implications on human health because of the animal-to-human transmission of diseases such as rabies, plaque, listeriosis, and query fever.

Veterinary vaccines and drugs administered prevent in the occurrence of human diseases and epidemics such as Ebola, West Nile Encephalitis, scabies, and anthrax. Some of the zoonotic diseases that can be prevented and controlled with timely vaccines and drugs include foot and mouth disease, bluetongue, brucellosis, hemorrhagic septicemia, rift valley fever, and contagious bovine pleuropneumonia. According to the Animal Cancer Foundation in the U.S., there is 6 million new cancer diagnosed in dogs and cats every year. According to studies by the Association for Pet Obesity Prevention (APOP), it was estimated that 58% of dogs and 54% of the cats in the U.S. are overweight or obese leading to a greater animal diabetes diagnosis.

Factors responsible to drive the global veterinary chemistry analyzers market are rising prevalence of animal diseases, growing incidences of zoonotic diseases (animal to human transmission), increase in pet ownership, increased demand for meat and animal-based products, usage of animals in agriculture, easy accessibility and affordability of treatment, increasing awareness of animal health & welfare, and increasing animal adoption.

However, factors limiting the growth of the global veterinary chemistry analyzers are the high cost of veterinary chemistry analyzers such as purchasing, installation & maintenance. Also, the dearth of technologically skilled veterinary professionals operating the analyzers is responsible to restrain the veterinary chemistry analyzers market growth.

Key Players Covered

Some of the key players that are present in the global veterinary chemistry analyzers market are IDEXX Laboratories, Inc., Randox Laboratories Ltd., Heska, DiaSys Diagnostic Systems GmbH, Urit Medical Electronic Co., Ltd., Abaxis, Biochemical Systems International (BSI), Eurolyser Diagnostica GmbH, Carolina Liquid Chemistries, and others.

SEGMENTATION

Among the segmentation, bench-top analyzers in the analyzer type segment accounted for a larger share owing to their accuracy and precision. Portable analyzers are expected to witness a higher CAGR during the forecast period owing to surging demand for shorter analysis time and quicker results.

Key Insights

• Prevalence of major veterinary diseases in key countries
• Pricing analysis
• Key industry developments in the global veterinary chemical analyzers market
• Key mergers and acquisitions

Regional Analysis

Geographically, the global veterinary chemistry analyzer market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global veterinary chemistry analyzers market owing to several factors such as the rising pet adoption rates, increasing prevalence of animal diseases especially zoonotic and infectious, increasing expenditure on animal health, a growing pool of veterinarians and a large number of hospitals & clinics. The Asia Pacific is the fastest emerging market due to large livestock animal pool, increasing incidences of animal disorders, increasing awareness of animal welfare, and introduction of government initiatives.

Key Industry Developments

• In January 2019, IDEXX Laboratories, Inc., announced the expansion of catalyst diagnostic menu and broadened the medical utility of SEDIVUE Analyzer. The additions include canine progesterone test and ability to assess liver function and blood disorders.
• In May 2018, Zoetis Inc., and Abaxis Inc., announced the definitive merger agreement, as Zoetis Inc. will acquire Abaxis Inc. to enhance its presence in veterinary diagnostics.
• In January 2018, Abaxis Inc., announced the approval by USDA, Center for Veterinary Biologics, for its new VETSCAN FLEX4 Rapid Test for veterinary use.